BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15327527)

  • 21. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition.
    Weber A; Hengge UR; Bardenheuer W; Tischoff I; Sommerer F; Markwarth A; Dietz A; Wittekind C; Tannapfel A
    Oncogene; 2005 Oct; 24(44):6699-708. PubMed ID: 16007169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
    Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
    J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer.
    He B; You L; Uematsu K; Zang K; Xu Z; Lee AY; Costello JF; McCormick F; Jablons DM
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14133-8. PubMed ID: 14617776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.
    Komazaki T; Nagai H; Emi M; Terada Y; Yabe A; Jin E; Kawanami O; Konishi N; Moriyama Y; Naka T; Kishimoto T
    Jpn J Clin Oncol; 2004 Apr; 34(4):191-4. PubMed ID: 15121754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction.
    Losman JA; Chen XP; Hilton D; Rothman P
    J Immunol; 1999 Apr; 162(7):3770-4. PubMed ID: 10201892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia.
    Liu TC; Lin SF; Chang JG; Yang MY; Hung SY; Chang CS
    Br J Haematol; 2003 Nov; 123(4):654-61. PubMed ID: 14616969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of DNMT1 Gene Silencing on Methylation of SOCS-1 Gene in Myeloma Cells].
    Wang Z; Niu XQ; Zhou WW; Lu QY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):713-7. PubMed ID: 26117023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2004 Aug; 83(8):527-32. PubMed ID: 14762685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines.
    Santangelo C; Scipioni A; Marselli L; Marchetti P; Dotta F
    Eur J Endocrinol; 2005 Mar; 152(3):485-9. PubMed ID: 15757867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic alterations complement mutation of JAK2 tyrosine kinase in patients with BCR/ABL-negative myeloproliferative disorders.
    Jost E; do O N; Dahl E; Maintz CE; Jousten P; Habets L; Wilop S; Herman JG; Osieka R; Galm O
    Leukemia; 2007 Mar; 21(3):505-10. PubMed ID: 17230231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.
    Ueki K; Kondo T; Kahn CR
    Mol Cell Biol; 2004 Jun; 24(12):5434-46. PubMed ID: 15169905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease.
    Greenhalgh CJ; Miller ME; Hilton DJ; Lund PK
    Gastroenterology; 2002 Dec; 123(6):2064-81. PubMed ID: 12454862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The suppressors of cytokine signalling (SOCS).
    Kile BT; Alexander WS
    Cell Mol Life Sci; 2001 Oct; 58(11):1627-35. PubMed ID: 11706989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyrotropin induces SOCS-1 (suppressor of cytokine signaling-1) and SOCS-3 in FRTL-5 thyroid cells.
    Park ES; Kim H; Suh JM; Park SJ; Kwon OY; Kim YK; Ro HK; Cho BY; Chung J; Shong M
    Mol Endocrinol; 2000 Mar; 14(3):440-8. PubMed ID: 10707961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia.
    Chen CY; Tsay W; Tang JL; Shen HL; Lin SW; Huang SY; Yao M; Chen YC; Shen MC; Wang CH; Tien HF
    Genes Chromosomes Cancer; 2003 Jul; 37(3):300-5. PubMed ID: 12759928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor of cytokine signaling 1, a newly proposed tumor suppressor gene associated with hepatocellular carcinoma.
    Ohkawa K
    J Gastroenterol; 2004 Jun; 39(6):598-600. PubMed ID: 15235884
    [No Abstract]   [Full Text] [Related]  

  • 39. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
    Flotho C; Paulun A; Batz C; Niemeyer CM
    Br J Haematol; 2007 Sep; 138(5):644-50. PubMed ID: 17686059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor.
    Dey BR; Furlanetto RW; Nissley P
    Biochem Biophys Res Commun; 2000 Nov; 278(1):38-43. PubMed ID: 11071852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.